Corteva Agriscience rings in the NYSE while Evogene’s Canonic targets medical cannabis.
As Corteva Agriscience rang in today’s session of the New York Stock Exchange, celebrating its independence from DowDupont, I couldn’t help but think about Big Ag’s flirtation with cannabis, especially after CEO Jim Collins referred to Corteva as “a new kind of agriculture company.”
In the wake of the Phylos controversy, many are wondering about the need for DNA sequence information in patents. That’s a complicated question in some ways, because the answer has some layers and explanations to it. But, in another way, it’s a very simple question. So let’s start with simple: how much DNA sequence information […]